Last update:

HIV & AIDS news

US approves cheap generic of breakthrough HIV shot for poorer countries

The U.S. Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in low-income countries.

Safer solutions: The urgent connection between smoking and HIV

People with HIV now lose more years of life to smoking than to HIV itself. About 1.2 million Americans are living with HIV, and while smoking among U.S. adults has fallen below 10% for the first time, people with HIV still ...

Using AI in the global fight against HIV

When faced with the possibility of an HIV diagnosis, sometimes the best initial prescription is support from a trusted friend—someone who might offer not just emotional guidance but also critical, practical health resources. ...

Has Taylor Swift defanged the toxic term 'Patient Zero' ?

On Sept. 22, Taylor Swift made an unexpected announcement that she was releasing a new single called "Patient Zero." The news sent Swifties and music sleuths on a wild goose chase for online clues to the meaning of the song ...

How a new long-acting HIV drug combo tackles resistance

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.

How a specific protein may drive brain damage in neuroHIV

While powerful medications can suppress the spread of HIV and its progression to AIDS, there are no cures, and many people living with HIV experience nervous system problems. Called neuroHIV, these complications occur when ...

Teaching the immune system to control HIV

There is no cure for HIV. While scientists have made considerable progress in controlling the infection, patients still must take daily antiretroviral medication for the rest of their lives. Results from a clinical trial ...

Fiji declares national HIV crisis

Fiji has declared a national HIV crisis as sexual transmission and illicit drug use help spread the virus, now infecting an estimated one in 60 adults in the Pacific nation.

What are we dying from?

Cardiovascular diseases now account for a third of deaths in adults over 40 in a rural South African population.

FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...

HIV disrupts lung 'clock,' raising COPD and emphysema risk

People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...

Long-acting HIV shots appeal to many but uptake remains low

When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living ...

Gut bacteria linked to levels of latent HIV

The composition of gut bacteria appears to be associated with how much latent HIV remains in the blood of people receiving antiretroviral therapy. This is shown in a new study from Karolinska Institutet, published in Gut ...